Thursday, October 10, 2024
HomeWell BodyHair LossIs There a Link Between Hair Loss and Testosterone Levels?

Is There a Link Between Hair Loss and Testosterone Levels?

A study published in JAMA Dermatology looks at the possible relationship between hair loss and testosterone levels.

Androgenic alopecia, more commonly known as male-pattern baldness, is the most common type of hair loss affecting both men and women.

It affects approximately 50% of males by the time they are 50 years old.

For generations, it has been suggested that there is a relationship between scalp hair loss and testosterone levels, with studies done in vitro (an experiment conducted outside of a living organism in a controlled environment) showing that indeed sex hormones such as testosterone inhibit hair growth.

No observable link according to the study

However, a study by Kische and colleagues published in JAMA Dermatology measured the serum concentration of sex hormones and hair loss in men from the general population of Northeast Germany and reports that there is no observable link.

The main regulators of human hair follicles are androgens, sex steroid hormones that stimulate hair growth in both sexes. The primary and most well-known androgen is testosterone and the second most commonly known is dihydrotestosterone (DHT).

Generally, hair loss is typically characterized as androgen-responsive hair loss

Androgens elicit effects like hair growth by binding with receptors on cell surface membranes. The response due to binding varies depending on the receptor location in the body.

In genetically predisposed individuals, hair loss is typically characterized as androgen-responsive hair loss. A decrease in scalp hair follicle size caused by DHT and a decrease in the duration of androgen, combined with an increase in miniaturized hair follicles (shorter and finer hairs) is the hallmark of androgenic alopecia.

Cross-sectional population study

A cross-sectional population study conducted in Northeastern Germany examined 373 men from the general population who had not received prescribed drugs in the past 7 days.

Blood samples were taken from each participant and a panel of liquid chromatography-mass spectrometry measurements was conducted and analyzed to determine the serum concentration of sex hormones.

In addition, the dermatologist examined each participant and assessed general hair loss (yes or no).

What the analysis revealed

The analysis revealed no significant relationship between general hair loss and testosterone levels in men from the general population. When men with and without general hair loss were compared, there was no observable difference in androgen concentrations.

With regards to androgenic alopecia and premature balding, these findings were consistent with previous studies that consisted of smaller sample sizes and selected participants.

Although higher levels of testosterone are suggested to increase the level of DHT, which in turn stimulates androgen action on hair follicles characteristic of male pattern baldness, this study observed no link between hair loss and testosterone levels.

Conclusions

These results are therefore consistent with previous research which suggests that an increase in androgen sensitivity or the number of androgen receptors may be the cause of androgenic alopecia, rather than the concentration of androgens like testosterone present in the body.

Lacey Hizartzidis PhD
Lacey Hizartzidis PhD
Lacey has a Ph.D. in Medicinal Chemistry from the University of Newcastle in Australia. Her research investigated the use of flow chemistry to synthesize potential anti-cancer agents. Having authored a number of articles published in international journals, she has developed a love for writing. Coupled with her passion for science and health, Lacey truly enjoys writing for Medical News Bulletin and helping people to understand the important and exciting scientific research being conducted around the world. With an adventurous spirit, Lacey also enjoys travelling the world, living a healthy life and helping others to do so as well.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

ANKTIVA Boosts BCG for Bladder Cancer

The FDA has approved the immunotherapy-boosting drug, ANKTIVA, to be used with the existing immunotherapy drug, Bacillus Calmette-Guerin (BCG). This new therapy is a...

Joke Of The Day

Patient: Doctor, I think there are two of me. Psychiatrist: Well, why don’t you both sit down and one of you tell me all about it.

ADVERTISE WITH US

error: Content is read-only and copy-protected.